Examining the Current Role of CAR T-Cell Therapy in Acute Myeloid Leukemia
June 7th 2019Jae H. Park, MD, discusses the current role and challenges in using CAR T-cell therapy in patients with relapsed or refractory acute myeloid leukemia. The 2 challenges now in this area are target selection and patient selection.